- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Russian COVID Vaccine: India to get Sputnik V by may end, says Dr Reddys
![Russian COVID Vaccine: India to get Sputnik V by may end, says Dr Reddys Russian COVID Vaccine: India to get Sputnik V by may end, says Dr Reddys](https://medicaldialogues.in/h-upload/2020/09/04/750x450_133999-dr-reddy.webp)
New Delhi: India will start receiving Russia's Sputnik V Covid-19 vaccine by end-May, its local distributor Dr. Reddy's Laboratories told Reuters on Thursday, a later than expected schedule that could slow the country's immunisation drive.
"We are targeting to have the first batches imported by (fiscal) Q1, and are trying our best to have them by end-May," Dr. Reddy's spokesman told Reuters. "Sputnik is going to be made in India in a few months. We expect the India-made vaccine to start being available from the second quarter of the fiscal (year)."
India's ambassador to Moscow said last week deliveries of Sputnik V to the country were expected to begin this month, the TASS news agency reported.
India recorded the world's highest daily tally of 314,835 new Covid-19 infections on Thursday as a second wave of the pandemic raised new fears about the ability of crumbling health services to cope.
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story